warnings
Warnings For external use only
Pink Eczema Cream
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Pink Eczema Cream
- Generic name
- COLLOIDAL OATMEAL
- Manufacturer
- MOOGOO SKIN CARE PTY LTD
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 3b8d92d0-ab7f-8dd5-e063-6394a90aa3af
- SPL ID
- 42c2cf85-8af3-6d7b-e063-6294a90a5092
- Version
- 4
- Effective date
- 2025-11-04
- Source export date
- 2026-11-06
- Source partition
- 5
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/bbdc0a42bf44145a63c3752991067bece7e2a518be6cc14943d33c4987faa012/drug-label-0005-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 07:15:14
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M016 | openfda.application_number | |
| brand name | Pink Eczema Cream | openfda.brand_name | |
| generic name | COLLOIDAL OATMEAL | openfda.generic_name | |
| manufacturer name | MOOGOO SKIN CARE PTY LTD | openfda.manufacturer_name | |
| ndc | package | 87043-0012-2 | openfda.package_ndc |
| ndc | product | 87043-0012 | openfda.product_ndc |
| ndc11 | package | 87043001202 | derived:openfda.package_ndc |
| spl id | 42c2cf85-8af3-6d7b-e063-6294a90a5092 | id | |
| spl set id | 3b8d92d0-ab7f-8dd5-e063-6394a90aa3af | set_id | |
| unii | 8PI54V663Y | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
warnings and cautions
When using this product Do not get into eyes
warnings and cautions
Stop use and ask a doctor if: Conditions worsens Symptoms last more than 7 days or clear up and occur again within a few days.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.